Autism Impact Fund

Autism Impact Fund is a New York-based venture fund investing exclusively in companies that diagnose, treat, and support individuals with autism spectrum disorder. Its narrow vertical focus is unusual in healthcare venture and reflects a stated mission orientation around outcomes for autistic individuals and their families. Founders building autism-specific diagnostics, digital therapeutics, ABA technology, family support tools, school-based intervention software, or care coordination platforms within the autism ecosystem fit the thesis. The fund occupies space in mental and behavioral health and digital health, but always through an autism-specific lens.

The fund invests at Seed and Series A with checks of $1M to $5M. It is based in the United States. There is no stated AI focus. Its category specialization means founders can expect domain-fluent diligence rather than generalist health tech evaluation.

Founders should approach with clarity on the autism-specific user population they serve, clinical or educational evidence supporting their approach, and a sustainable business model given the fragmented payer and school-district reimbursement landscape. Authentic engagement with the autism community, including autistic individuals and families, will resonate. Limited public information is available about specific partners or portfolio companies beyond the fund’s stated mandate, so direct outreach via the firm’s website or referrals through autism clinical and advocacy networks are reasonable paths in.